Citations

Clear

16280 citation(s) found for "Yu, David".

A Computational Method to Classify Variants of Uncertain Significance Using Functional Assay Data with Application to BRCA1
Iversen, Edwin S. , Goldgar, David E., Tavtigian, Sean V. , Monteiro, Álvaro N.A. , Couch, Fergus J. , Goldgar, David E., Monteiro, Alvaro N

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 7, 2011 | Volume: 20 | Issue: 6 | Pages: 1078-1088

10.1158/1055-9965.epi-10-1214 | PMID 21447777 Get It

Abstract Background: Besides revealing cancer predisposition variants or the absence of any changes, genetic testing for cancer predisposition genes can also identify variants of uncertain clinical significance (VUS). Classifying VUSs is a pressing problem, as ever more patients seek genetic testing for disease syndromes and receive noninformative results from those tests. In cases such as the breast and ovarian cancer syndrome in which prophylactic options can be severe and life changing, having information on the disease relevance of the VUS that a patient harbors can be critical. Methods: We describe a computational approach for inferring the disease relevance of VUSs in disease genes from data derived from an in vitro functional assay. It is based on a Bayesian hierarchical model that accounts for sources of experimental heterogeneity. Results: The functional data correlate well with the pathogenicity of BRCA1 BRCT VUSs, thus providing evidence regarding pathogenicity when family and genetic data are absent or uninformative. Conclusions: We show the utility of the model by using it to classify 76 VUSs located in the BRCT region of BRCA1. The approach is both sensitive and specific when evaluated on variants previously classified using independent sources of data. Although the functional data are very informative, they will need to be combined with other forms of data to meet the more stringent requirements of clinical application. Impact: Our work will lead to improved classification of VUSs and will aid in the clinical decision making of their carriers. Cancer Epidemiol Biomarkers Prev; 20(6); 1078–88. ©2011 AACR.
Inherited Variants in Mitochondrial Biogenesis Genes May Influence Epithelial Ovarian Cancer Risk
Permuth‐Wey, Jennifer, Chen, Y. Ann , Tsai, Ya-Yu, Chen, Zhihua , Qu, Xiaotao , Lancaster, Johnathan M., Stockwell, Heather, Dagne, Getachew , Iversen, Edwin S., Barnholtz‐Sloan, Jill S. , Cunningham, Julie M. , Vierkant, Robert A. , Sutphen, Rebecca , McLaughlin, John, Narod, Steven A., Goode, Ellen L. , Schildkraut, Joellen M. , Fenstermacher, David, Phelan, Catherine M., Sellers, Thomas A. , Risch, Harvey A. , Fridley, Brooke L. , McLaughlin, John, Vierkant, Robert A , Barnholtz-Sloan, Jill S

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | June 7, 2011 | Volume: 20 | Issue: 6 | Pages: 1131-1145

10.1158/1055-9965.epi-10-1224 | PMID 21447778 Get It

Abstract Background: Mitochondria contribute to oxidative stress, a phenomenon implicated in ovarian carcinogenesis. We hypothesized that inherited variants in mitochondrial-related genes influence epithelial ovarian cancer (EOC) susceptibility. Methods: Through a multicenter study of 1,815 Caucasian EOC cases and 1,900 controls, we investigated associations between EOC risk and 128 single nucleotide polymorphisms (SNPs) from 22 genes/regions within the mitochondrial genome (mtDNA) and 2,839 nuclear-encoded SNPs localized to 138 genes involved in mitochondrial biogenesis (BIO, n = 35), steroid hormone metabolism (HOR, n = 13), and oxidative phosphorylation (OXP, n = 90) pathways. Unconditional logistic regression was used to estimate OR and 95% CI between genotype and case status. Overall significance of each gene and pathway was evaluated by using Fisher's method to combine SNP-level evidence. At the SNP level, we investigated whether lifetime ovulation, hormone replacement therapy (HRT), and cigarette smoking were confounders or modifiers of associations. Results: Interindividual variation involving BIO was most strongly associated with EOC risk (empirical P = 0.050), especially for NRF1, MTERF, PPARGC1A, ESRRA, and CAMK2D. Several SNP-level associations strengthened after adjustment for nongenetic factors, particularly for MTERF. Statistical interactions with cigarette smoking and HRT use were observed with MTERF and CAMK2D SNPs, respectively. Overall variation within mtDNA, HOR, and OXP was not statistically significant (empirical P > 0.10). Conclusion: We provide novel evidence to suggest that variants in mitochondrial biogenesis genes may influence EOC susceptibility. Impact: A deeper understanding of the complex mechanisms implicated in mitochondrial biogenesis and oxidative stress may aid in developing strategies to reduce morbidity and mortality from EOC. Cancer Epidemiol Biomarkers Prev; 20(6); 1131–45. ©2011 AACR.
Hemodynamic Changes Induced by Pneumoperitoneum and Measured With ECOM
Shine, Timothy, Corda, David M. , Leone, Bruce J. , Feinglass, Neil G., Brull, Sorin J. , Han, Booyeon J., Aniskevich, Stephen , Brull, Sorin J

Mayo Clinic

Journal of Medical Devices | June 4, 2011 | Volume: 5 | Issue: 2 | Pages: No page available

10.1115/1.3589225 Get It

Biomechanical comparison of three fixation techniques used for four-corner arthrodesis
Kraisarin, Jirachart, Dennison, David G., Berglund, Lars , An, Kai‐Nan , Shin, Alexander Y. , Shin, Alexander Y

Mayo Clinic

Journal of Hand Surgery (European Volume) | June 3, 2011 | Volume: 36 | Issue: 7 | Pages: 560-567

10.1177/1753193411406799 | PMID 21636620 Get It

Clinical results following four-corner arthrodesis vary and suggest that nonunion may be related to certain fixation techniques. The purpose of our study was to examine the displacement between the lunate and capitate following a simulated four-corner arthrodesis with the hypothesis that three types of fixation (Kirschner wires, dorsal circular plate, and a locked dorsal circular plate) would allow different amounts of displacement during simulated wrist flexion and extension. Cadaver wrists with simulated four-corner arthrodeses were loaded cyclically either to implant failure or until the lunocapitate displacement exceeded 1 mm. The locked dorsal circular plate group was significantly more stable than the dorsal circular plate and K-wire groups ( p = 0.018 and p = 0.006). While these locked dorsal circular plates appear to be very stable our results are limited only to the biomechanical behavior of these fixation techniques within a cadaver model.
Risk of Recurrent Cardiac Events After Onset of Menopause in Women With Congenital Long-QT Syndrome Types 1 and 2
Buber, Jonathan , Mathew, Jehu, Moss, Arthur J. , Barsheshet, Alon , McNitt, Scott , Zaręba, Wojciech , Ackerman, Michael J. , Kaufman, Elizabeth S. , Luria, David , Eldar, Michael, Towbin, Jeffrey A. , Vincent, Michael, Hall, William Jackson , Robinson, Jennifer L. , Goldenberg, Ilan , Zareba, Wojciech

Mayo Clinic

Circulation | June 1, 2011 | Volume: 123 | Issue: 24 | Pages: 2784-2791

10.1161/circulationaha.110.000620 | PMID 21632495 Get It

Background—Women with congenital long-QT syndrome experience an increased risk for cardiac events after the onset of adolescence that is more pronounced among carriers of the LQT2 genotype. We hypothesized that the hormonal changes associated with menopause may affect clinical risk in this population.Methods and Results—We used a repeated-events analysis to evaluate the risk for recurrent syncope during the menopause transition and postmenopausal periods (5 years before and after the age at onset of menopause, respectively) among 282 LQT1 (n=151) and LQT2 (n=131) women enrolled in the Long-QT Syndrome Registry. Multivariate analysis showed that the risk for recurrent syncope (n=150) among LQT2 women was significantly increased during both menopause transition (hazard ratio, 3.38;P=0.005) and the postmenopausal period (hazard ratio, 8.10;P<0.001) compared with the reproductive period. The risk increase was evident among women who did or did not receive estrogen therapy. In contrast, among LQT1 women, the onset of menopause was associated with a reduction in the risk for recurrent syncope (hazard ratio, 0.19;P=0.05;P=0.02 for genotype-by-menopause interaction). Only 22 women (8%) experienced aborted cardiac arrest or sudden cardiac death during follow-up. The frequency of aborted cardiac arrest/sudden cardiac death showed a similar genotype-specific association with the onset of menopause.Conclusions—The onset of menopause is associated with a significant increase in the risk of cardiac events (dominated by recurrent episodes of syncope) in LQT2 women, suggesting that careful follow-up and continued long-term therapy are warranted in this population.
Predicting survival in frontotemporal dementia with motor neuron disease
Sorenson, Eric J. , Whitwell, Jennifer L. , Josephs, Keith A. , Coon, Elizabeth A. , Knopman, David S.

Mayo Clinic

Neurology | May 30, 2011 | Volume: 76 | Issue: 22 | Pages: 1886-1892

10.1212/wnl.0b013e31821d767b | PMID 21624986 Get It

Incidence and Symptoms of High Altitude Illness in South Pole Workers: Antarctic Study of Altitude Physiology (ASAP)
Anderson, Paul J., O’Malley, Kathy A., Ceridon, Maile L., Beck, Kenneth C., Wood, Christina M., Wiste, Heather J. , Mueller, J. , Johnson, Jacob, Johnson, Bruce D., Miller, Andrew David

Mayo Clinic

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | May 29, 2011 | Volume: 5 | Issue: No issue available | Pages: CCRPM.S6882

10.4137/ccrpm.s6882 | PMID 21695160 Get It

Introduction Each year, the US Antarctic Program rapidly transports scientists and support personnel from sea level (SL) to the South Pole (SP, 2835 m) providing a unique natural laboratory to quantify the incidence of acute mountain sickness (AMS), patterns of altitude related symptoms and the field effectiveness of acetazolamide in a highly controlled setting. We hypothesized that the combination of rapid ascent (3 hr), accentuated hypobarism (relative to altitude), cold, and immediate exertion would increase altitude illness risk. Methods Medically screened adults (N = 246, age = 37 ± 11 yr, 30% female, BMI = 26 ± 4 kg/m 2 ) were recruited. All underwent SL and SP physiological evaluation, completed Lake Louise symptom questionnaires (LLSQ, to define AMS), and answered additional symptom related questions (eg, exertional dyspnea, mental status, cough, edema and general health), during the 1st week at altitude. Acetazolamide, while not mandatory, was used by 40% of participants. Results At SP, the barometric pressure resulted in physiological altitudes that approached 3400 m, while T ° C averaged -42, humidity 0.03%. Arterial oxygen saturation averaged 89% ± 3%. Overall, 52% developed LLSQ defined AMS. The most common symptoms reported were exertional dyspnea-(87%), sleeping difficulty-(74%), headache-(66%), fatigue-(65%), and dizziness/lightheadedness-(46%). Symptom severity peaked on days 1-2, yet in >20% exertional dyspnea, fatigue and sleep problems persisted through day 7. AMS incidence was similar between those using acetazolamide and those abstaining (51 vs. 52%, P = 0.87). Those who used acetazolamide tended to be older, have less altitude experience, worse symptoms on previous exposures, and less SP experience. Conclusion The incidence of AMS at SP tended to be higher than previously reports in other geographic locations at similar altitudes. Thus, the SP constitutes a more intense altitude exposure than might be expected considering physical altitude alone. Many symptoms persist, possibly due to extremely cold, arid conditions and the benefits of acetazolamide appeared negligible, though it may have prevented more severe symptoms in higher risk subjects.
Myocardial Infarction After Carotid Stenting and Endarterectomy
Blackshear, Joseph L., Cutlip, Donald E. , Roubin, Gary S., Hill, Michael D. , Leimgruber, Pierre P., Begg, Richard J., Eidt, John F. , Narins, Craig R. , Prineas, Ronald J. , Glasser, Stephen P. , Voeks, Jenifer H. , Brott, Thomas G. , Investigators, for the CREST, Cohen, David Jonathan , Investigators, for the CREST, Hill, Michael D

Mayo Clinic

Circulation | May 24, 2011 | Volume: 123 | Issue: 22 | Pages: 2571-2578

10.1161/circulationaha.110.008250 | PMID 21606394 Get It

Background— The Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST) found a higher risk of stroke after carotid artery stenting and a higher risk of myocardial infarction (MI) after carotid endarterectomy. Methods and Results— Cardiac biomarkers and ECGs were performed before and 6 to 8 hours after either procedure and if there was clinical evidence of ischemia. In CREST, MI was defined as biomarker elevation plus either chest pain or ECG evidence of ischemia. An additional category of biomarker elevation with neither chest pain nor ECG abnormality was prespecified (biomarker+ only). Crude mortality and risk-adjusted mortality for MI and biomarker+ only were assessed during follow-up. Among 2502 patients, 14 MIs occurred in carotid artery stenting and 28 MIs in carotid endarterectomy (hazard ratio, 0.50; 95% confidence interval, 0.26 to 0.94; P =0.032) with a median biomarker ratio of 40 times the upper limit of normal. An additional 8 carotid artery stenting and 12 carotid endarterectomy patients had biomarker+ only (hazard ratio, 0.66; 95% confidence interval, 0.27 to 1.61; P =0.36), and their median biomarker ratio was 14 times the upper limit of normal. Compared with patients without biomarker elevation, mortality was higher over 4 years for those with MI (hazard ratio, 3.40; 95% confidence interval, 1.67 to 6.92) or biomarker+ only (hazard ratio, 3.57; 95% confidence interval, 1.46 to 8.68). After adjustment for baseline risk factors, both MI and biomarker+ only remained independently associated with increased mortality. Conclusions— In patients randomized to carotid endarterectomy versus carotid artery stenting, both MI and biomarker+ only were more common with carotid endarterectomy. Although the levels of biomarker elevation were modest, both events were independently associated with increased future mortality and remain an important consideration in choosing the mode of carotid revascularization or medical therapy. Clinical Trial Registration— URL: http://www.ClinicalTrials.gov . Unique identifier: NCT00004732.
Cardiovascular Magnetic Resonance, 2nd ed.
Stoffey, Robert D., Ladapo, Joseph A. , Ladapo, Joseph A

Mayo Clinic

American Journal of Roentgenology | May 23, 2011 | Volume: 196 | Issue: 6 | Pages: W853-W853

10.2214/ajr.10.6190 Get It

Language and behavior domains enhance the value of the clinical dementia rating scale
Weıntraub, Sandra , Knopman, David S. , Pankratz, V. Shane

Mayo Clinic

Alzheimer's & Dementia | May 21, 2011 | Volume: 7 | Issue: 3 | Pages: 293-299

10.1016/j.jalz.2010.12.006 | PMID 21575870 Get It

BackgroundThe six domain standard Clinical Dementia Rating Scale (CDRstd) has been successful for staging patients with the clinical syndrome of probable Alzheimer's disease (AD). The CDRstd does not specifically address language dysfunction or alteration in personality and social behaviors which are prominent in behavioral variant frontotemporal dementia (bvFTD) and primary progressive aphasia (PPA).ObjectiveTo determine the value of adding domains of Language (LANG), and Behavior, Comportment, and Personality (BEHAV) to the CDRstd for the evaluation of patients with bvFTD and PPA.MethodsTwo new domains, LANG and BEHAV, were constructed to parallel the six domains sampled in the CDRstd. Clinical and neuropsychological test data were obtained from the National Alzheimer's Coordinating Center. The dataset contained information on 2550 probable AD, 88 vascular dementia, 281 dementia with Lewy body, 234 bvFTD, and 137 PPA patients.ResultsThere were 76.5% of bvFTD and 99.3% of PPA patients with abnormal ratings (>0) on the LANG domain; 90.2% of bvFTD and 63.5% of PPA had abnormal ratings on the BEHAV domain. In patients with a CDRstd sum of boxes score of <4, 53.7% of bvFTD had BEHAV domain and 78.6% of PPA patients had LANG domain scores >1. Among probable AD patients, 3.7% had LANG ratings that were ≥1 and 3.8% had BEHAV ratings that were ≥1. Logistic regression analyses showed that adding either the LANG or BEHAV domains to the CDRstd sum of boxes score significantly improved the discrimination between probable AD, bvFTD, and PPA.ConclusionsThe new LANG and BEHAV domains add value to the CDRstd for the characterization of the nonamnestic symptoms that are prominent in patients with bvFTD and PPA but that also occur in those with probable AD.